Is it time to consider glaucoma screening cost-effective? - Authors' reply

Affiliations

¹ School of Agricultural Economics and Rural Development, Renmin University of China, Beijing, China; Centre for Public Health, Queen's University Belfast, Belfast, UK.
² Centre for Public Health, Queen's University Belfast, Belfast, UK; Orbis International, New York, NY, USA.
³ The Eye Hospital, School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China. Electronic address: yuanboliang@126.com.

Free article

Comment

Jianjun Tang et al. Lancet Glob Health. 2019 Nov.

Free article

. 2019 Nov;7(11):e1491.

doi: 10.1016/S2214-109X(19)30398-5.

¹ School of Agricultural Economics and Rural Development, Renmin University of China, Beijing, China; Centre for Public Health, Queen's University Belfast, Belfast, UK.
² Centre for Public Health, Queen's University Belfast, Belfast, UK; Orbis International, New York, NY, USA.
³ The Eye Hospital, School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China. Electronic address: yuanboliang@126.com.

No abstract available

Comment on

Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
Tang J, Liang Y, O'Neill C, Kee F, Jiang J, Congdon N. Tang J, et al. Lancet Glob Health. 2019 Jul;7(7):e968-e978. doi: 10.1016/S2214-109X(19)30201-3. Epub 2019 May 20. Lancet Glob Health. 2019. PMID: 31122906
Is it time to consider glaucoma screening cost-effective?
Kanclerz P, Grzybowski A, Tuuminen R. Kanclerz P, et al. Lancet Glob Health. 2019 Nov;7(11):e1490. doi: 10.1016/S2214-109X(19)30395-X. Lancet Glob Health. 2019. PMID: 31607458 No abstract available.